Chemoinformaics analysis of [(Z)-HEX-3-ENYL] OCTANOATE
| Molecular Weight | 226.36 | nRot | 10 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 12 |
| Exact Molecular Weight | 226.193 | nRing | 0 |
| Solubility: LogS | -4.849 | nHRing | 0 |
| Solubility: LogP | 4.664 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.3206 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.543 |
| Synth | 4.359 |
| Natural Product Likeliness | 2.258 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.129 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.439 |
| MDCK | 0.00000821 |
| BBB | 0.12 |
| PPB | 0.911835 |
| VDSS | 2.323 |
| FU | 0.0892483 |
| CYP1A2-inh | 0.911 |
| CYP1A2-sub | 0.697 |
| CYP2c19-inh | 0.859 |
| CYP2c19-sub | 0.88 |
| CYP2c9-inh | 0.725 |
| CYP2c9-sub | 0.407 |
| CYP2d6-inh | 0.805 |
| CYP2d6-sub | 0.277 |
| CYP3a4-inh | 0.867 |
| CYP3a4-sub | 0.495 |
| CL | 12.848 |
| T12 | 0.198 |
| hERG | 0.014 |
| Ames | 0.004 |
| ROA | 0.052 |
| SkinSen | 0.919 |
| Carcinogencity | 0.824 |
| EI | 0.838 |
| Respiratory | 0.899 |
| NR-Aromatase | 0.461 |
| Antiviral | Yes |
| Prediction | 0.784263 |